1Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advance Studies (VISTAS), Pallavaram, Chennai - 600117, Tamil Nadu, India
2Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advance Studies (VISTAS), Pallavaram, Chennai - 600117, Tamil Nadu, India
*Corresponding Author E-mail: somous0926@gmail.com
Online published on 28 October, 2020.
This study aimed to investigate the short-term effects of salbutamol in Chronic obstructive pulmonary disease (COPD) patients and to assess the incidence of Hyperglycemia and Tachycardia. The study is a Prospective, observational study conducted in Department of General Medicine on a sample of 136 COPD patients. After administration of Nebulised salbutamol, the Heart Rate and Random Blood Sugar (RBS) levels of patients were assessed in two periods; baseline and after 24 hour. The Random Blood Sugar mean was significantly increased after 24 hour of nebulizer administration (p<0.0001). The Heart Rate mean was significantly increased after 24 hour of nebulizer administration (p<0.0001). The nebulizer applying salbutamol has a profound effect in increasing the Random Blood Sugar level and Heart Rate after 24 hours of administration.
Salbutamol, Hyperglycemia, Tachycardia, Random blood sugar, Heart Rate
